Using structure-based optimization procedures on previously identified in silico hits, two novel classes of compounds, i.e., dibenzosuberyl-and benzoate substituted tropines were designed and synthesized as ligands for acetylcholine-binding protein (AChBP). This protein is a homolog to the ligand binding domain of the nicotinic acetylcholine receptor (nAChR). The hit optimization was monitored and guided by ligand and group efficiency (LE and GE) considerations as well as structural information. Distinct SAR of the novel compound series is observed between two AChBP species variants and between the α7 and α4β2 nAChR subtype. The AChBP species differences are indicative of a difference in accessibility of a ligand-inducible subpocket between AChBPs from different species. Hereby, we have identified a region within the ligand binding site that can be scrutinized to achieve selectivity for nicotinic receptor subtypes.
Introduction
The neuronal nicotinic acetylcholine receptors (nAChRs) belong to the Cys-loop receptor family of the ligand-gated ion channels (LGICs). The Cys-loop receptors are characterized by a pentameric assembly of subunits. Until now, 12 human neuronal nAChR subunits (2-10 and 2-4) have been identified. These subunits combine to form either homopentamers (e.g., 7) or heteropentamers (e.g., 42), resulting in different pharmacological characteristics. [1] [2] [3] The most abundant nAChR subtypes in the central nervous system (CNS) are the 42 and the 7 receptors. 2 The 42 receptor is characterized by high affinity for nicotine, high permeability for Na + , K + , and low permeability for Ca 2+ ions. In contrast, the 7 receptor has lower affinity for nicotine, but high affinity for the snake toxin -bungarotoxin and the alkaloid methyllycaconitine (MLA). 2 In addition, the 7 receptor is permeable for Ca 2+ and Na + ions. 1, 2 Several important physiological and mental processes are regulated by nicotinic receptors and they are therefore potential therapeutic targets for a wide variety of neurodegenerative and psychiatric disorders. The human 42 and 7 receptors play a role in the pathophysiology of Alzheimer"s disease, Parkinson"s disease, schizophrenia, epilepsy and anxiety. [1] [2] [3] In addition, the human 42 nAChR is involved in nicotine addiction and pain. 2 Furthermore, the human 7 may also be of value as a pharmacological target in inflammation. 4, 5 Several nicotinic receptor ligands are being investigated for clinical use. The first clinical breakthrough was reported in 2006, when Varenicline, a partial agonist on the 42 nAChR, was approved as a drug for smoking cessation. 6, 7 Due to high sequence identity of the binding pockets of the different subtypes and lack of detailed structural information on nAChRs, the development of selective ligands remains a challenge. Furthermore, the lack of high resolution crystal structures of eukaryotic LGICs hampers a structure-based design approach to tackle this challenge. Fortunately, the water-soluble acetylcholine binding protein (AChBP) from the fresh water snail Lymnaea stagnalis (Ls-AChBP) has been characterized and crystallized. This protein is a widely accepted structural homolog of the extracellular domain (ECD) of nicotinic receptors 8, 9 The binding pocket of this homopentameric protein is situated at the interface of two adjacent subunits and is formed by the principal and complementary side, (Figure 1A-D) . 8 The principal side is formed by mostly aromatic residues of loops A (Tyr89, Ls-AChBP amino acid numbering), B (Trp143) and C (Tyr185 and Tyr192). In addition, the flexible loop C has two vicinal cysteines (Cys187-188) that form a disulfide bond. The complementary side is formed by loops D, E and F and only loop D donates an aromatic residue (Trp53) (Figure 1C-E) . Co-crystal structures of Ls-AChBP in complex with nicotine and carbamylcholine have revealed important interactions between these nicotinic receptor ligands and Ls-AChBP. 10 This includes the cation- interactions between a cationic center in nicotinic receptor ligands and Trp143. In addition, nicotine forms a hydrogen bond between its pyrolidine nitrogen atom and the carbonyl backbone of Trp143 ( Figure 1F ).
Figure 1: Cartoon and surface representation of 2.2 Å X-ray structure of AChBP from Lymnaea stagnalis in complex with nicotine (PDB: 1UW6) shown in side view (A) and top view (B). The binding site is located at the interface of two subunits (indicated by a black circle) and consists of a principal (C) and a complementary side (D). The AChBP homopentamer has five orthosteric and identical ligand binding sites. (E) A schematic representation showing the loops A-F that shape the orthosteric binding site. (F) Close up on the binding pose of nicotine bound to LsAChBP. Chapter 5 Structure-based design, synthesis, and structure-activity relationships of dibenzosuberyl-and benzoate substituted tropines as ligands for acetylcholine-binding protein
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After the identification of Ls-AChBP, similar binding proteins have been identified in other molluscan species, e.g., Aplysia californica (Ac-AChBP) and Bulinus truncatus AChBP (Bt-AChBP) and these proteins have been co-crystallized in the presence of nicotinic receptor ligands or buffer molecules. 11, 12 The crystal structures of the three different AChBPs show a conserved architectural fold that has been recognized as a template to understand the ligand binding domains of nicotinic receptors and other mammalian Cys-loop receptors. Crucial information on ligand-receptor interactions has been obtained from agonist-bound structures of AChBP, i.e., carbamylcholine, nicotine and epibatidine. 10, 12 Similar cation- interactions between a conserved tryptophan (loop B) and cationic centers of several nonpeptidic ligands are observed in these co-crystal structures. Experimental evidence has been obtained that identical interactions are present in neuronal nicotinic receptors, illustrating the use of AChBP in nAChR research. 13 Recently, we have described a study in which a benzoate substituted tropinecontaining fragment (18, Scheme 3) and several derivatives that interact with a ligand-inducible subpocket of the binding site of AChBP were thoroughly characterized using thermodynamic and structural analysis. 14 In another recent study, we have reported an in silico screening protocol that resulted in the identification of ligands with affinity for AChBP and the α7 but no affinity for the α4β2 nAChR. 15 Two of the identified hits contained a dibenzosuberyl-substituted tropine scaffold (1 and 2, Table 1 ) and were co-crystallized with Ac-AChBP. In the current study, we describe the structure-based design and synthesis of dibenzosuberyl-and benzoate substituted tropine derivatives and their SAR on Acand Ls-AChBP and on α7 and α4β2 nicotinic receptors. The hit optimization was monitored and guided by ligand efficiency and group efficiency considerations (LE and GE) as well as structural information.
Results and Discussion
Design
The previously obtained co-crystal structures of Ac-AChBP in complex with hit compounds 1 and 2 (PDB: 2W8F and 2W8G, respectively) show that the ligands have a comparable binding pose with their cationic nitrogen atoms forming cation- interactions with Trp145 (Ac-AChBP amino acid numbering, Trp143 in LsAChBP). 15 Structural comparison with previously obtained co-crystal complexes exemplifies the conformational flexibility of the AChBP binding site, in particular with respect to Loop C. The bulky dibenzosuberyl group of the in silico hits pushes loop C away from the binding pocket into an intermediate open conformation. Comparing the structures of Ac-AChBP in complex with 1 ( Figure 2A ) and lobeline (3, PDB: 2BYS, Figure 2B ) 12 , reveals the opening of the lobeline pocket by the rotameric change of Tyr91 (Tyr93 in 2BYS corresponds to Tyr91 in 2W8F), see Figure 2C . In addition, the superposition of both X-ray structures shows that the cationic nitrogen atoms of compound 1 and lobeline are at a similar position and engaged in cation- interactions with Trp145 ( Figure 2B ). The structural overlay To further optimize the interactions of the -hydroxyphenetyl moiety of hybrid compound 5 with the lobeline pocket, we designed analogs of 5 (4-7, Figure 3A , Table 1 ). These analogs were subsequently docked into the crystal structure of 1 (PDB: 2W8F) after opening of the lobeline pocket by manually changing the rotameric state of Tyr91 from the g-to t conformation) 17 . The obtained binding poses indicate that the lobeline pocket can indeed be addressed by the -hydroxyphenetyl moiety ( Figure 3B ). Further investigation of the docking results suggests that additional interactions with the binding site can be established by incorporation of hydroxyl moieties at the meta positions (one or both) of the phenyl ring. By doing so, it was anticipated that hydrogen bonds could be formed with the backbone carbonyl oxygen of Thr89 and the side chain of Asp195 ( Figure 3C ). Our in silico screening study has provided an indication that compounds 1 and 2 bind to both the orthosteric site and the ion pore of nAChRs. 15 The interaction with the ion pore may arise from the structural resemblance to tricyclic antidepressants that have been shown to block Na + channels. 18 In order to abolish the putative channel blockade of the tricyclic ligands, we performed an additional fragment-merging exercise affording new ligands, in which the dibenzosuberyl moiety was replaced by a smaller benzoate group (Table 2) . Thus, a set of benzoate substituted analogs was synthesized in order to determine the influence on the binding affinity of 1) the configuration of the epimeric C(3) position of the tropine spacer, 2) the quaternization of the tropine nitrogen atom, and 3) the introduction of hydroxyl substituted phenetyl moieties.
Chemistry
The dibenzosuberyl substituted tropinyl ethers were synthesized according to Scheme 1. Treatment of tropine with 5-chlorodibenzosuberane followed by oxidative demethylation with KMnO 4 afforded dibenzosuberyl ether 9. 19, 20 The corresponding phenetylamine 4 was obtained by reductive amination of 9 with phenylacetaldehyde. 21 Methylation using iodomethane afforded the quaternary ammonium salt 10 with the phenetyl moiety in an endo-configuration as determined by 2D NMR spectroscopy at 393 K. The mono and di-hydroxyl substituted phenetylamines 5 and 6 were obtained via TBTU-mediated coupling with the corresponding racemic mandelic acids, followed by LAH reduction. β-tropine (13) was prepared via Meerwein-Ponndorf-Verley reduction of tropinone using Al(iOPr) 3 . 22 The benzoate esters of α-and β-tropine (7, 8) were obtained by acylation with benzoyl chloride. 23 Subsequent demethylation using α-chloroethylchloroformate afforded the corresponding nortropinyl esters (16, 17) . 24 Similar as in the tricyclic series, phenetylamines 20 and 21 were obtained by reductive amination with phenylacetaldehyde. Treatment of endo-epimer 20 with iodomethane resulted in formation of the endo-phenetyl substituted quaternary ammonium derivative 22. The epimeric configuration was confirmed by performing 2D NMR (supplementary data). The mono and di-hydroxyl substituted phenetylamines 24-26 were synthesized via TBTU-mediated coupling with the corresponding phenylacetic acids, followed by BH 3 reduction. Reaction of -hydroxyl substituted phenetylamine 24 with iodomethane afforded similar as before the endo-phenetyl substituted quaternary ammonium derivative 23 as confirmed by 2D NMR (supplementary data). The tri-hydroxyl substituted endo-and exo-benzoate substituted Nphenetyltropines (29, 30) were obtained through alkylation of nortropinyl esters 18 and 19 with 2-bromo-1-(3,5-dihydroxyphenyl)ethanone (14) 
Pharmacology
The binding affinity data of the dibenzosuberyl-substituted compounds shows that removing methyl groups from the quaternary tropine nitrogen atoms reduces binding affinity for Ls-AChBP, see Table 1 (compare 1, 8 and 9). Extension of the methylene spacer of benzyl derivative 2 with one methylene unit affording the phenetyl substituted compound 4 resulted in a 0.4 log unit increase in affinity. Subsequent quaternization of the tropine nitrogen atom of 4 gave rise to an additional 0.4 log unit increase in binding affinity. In total, the affinity of the in silico identified hit 1 was increased 6-fold (10, pK i = 7.4). Introduction of hydroxyl groups at the -and meta positions of the phenetyl group of compound 4 diminished the affinity. It should be noted that both -hydroxyl substituted derivatives (5 and 6) were tested as racemic mixtures. Taken together, these results illustrate that for Ls-AChBP affinity, a quaternary tropine nitrogen atom is preferred and a lipophilic (Figure 4) . Particularly, fragment 18 with an LE > 0.4 kcal·mol -1 for both AChBP species variants, serves as an ideal starting point for further optimization. Similar to the tricyclic series, quaternization of the tropine nitrogen atom of benzoate substituted tropines results in increased affinity for Ls-AChBP (21 vs. 22 and 24 vs. 23). Extending fragment 18 with a phenetyl moiety on the tropine nitrogen atom affords compound 20 with a 10-fold increase in affinity. As seen with the dibenzosuberyl substituted derivatives, introduction of an -hydroxyl group to the phenetyl moiety results in a significant loss in affinity. This effect is observed for an unsubstituted phenetyl moiety (20 and 24) As such, the affinity of the tri-hydroxylsubstituted phenetylamine with an endo-configuration (29 pK i = 6.4) is lower than the affinity of the corresponding unsubstituted phenetylamine (compound 20, pKi = 7.1). The highest affinity (pK i = 7.5) was observed for the quaternary ammonium derivative 22.
Distinct SAR is observed for Ac-AChBP. One of the best dibenzosuberylsubstituted compounds in the Ls-AChBP assay (1) binds with 100-fold lower affinity to Ac-AChBP, suggesting that in contrast to Ls-AChBP, large hydrophobic substituents on a tertiary nitrogen atom are not allowed. Similar to Ls-AChBP, quaternization of the tropine nitrogen atom of N-phenetyl derivative 8 (affording 10) is beneficial, although the increase in affinity upon quaternization is more pronounced for Ac-AChBP, i.e., 1.2 log units compared to 0.4 log units, respectively. Similar to Ls-AChBP, introduction of hydroxyl functionalities on the Nphenetyl group"s  and meta position (5 and 6) does not result in increases in binding affinity. For Ac-AChBP binding affinity, the endo-epimer of benzoatesubstituted tropines is also preferred. However, in contrast to Ls-AChBP, quaternization of the tropine nitrogen atom results in significant decreases of affinity for Ac-AChBP (20 vs. 22 and 24 vs. 23). Introduction of a hydroxyl group at the  or two meta positions of the phenetyl moiety is not tolerated and the highest Ac-AChBP affinity is obtained for the unsubstituted phenetylamine 20 (pK i of 7.5). An interesting observation is that in contrast to all the other ligands, benzoate esters 20 and 24 exhibit a preference for Ac-over Ls-AChBP. Since 24 was tested as a racemic mixture, both enantiomers ((S)-31 and (R)-32) were synthesized revealing that only the (R)-enantiomer shows a preference for Ac-AChBP.
14 Whereas for Ls-AChBP, the SAR of the tropine substituents is almost identical for the dibenzosuberyl and benzoate series, in the case of Ac-AChBP clear SAR differences were observed when focusing on the tropine substituent. To exemplify these SAR differences, we have calculated both the ligand efficiency (LE) 26 and the group efficiency (GE) 27 of several of our newly designed ligands for both AChBP species variants (Figure 4) . For Ls-AChBP, we observed an identical GE value of 0.17 kcal·mol -1 per heavy atom for the addition of a phenetyl moiety to dibenzosuberyl nortropinyl ether 9 (affording 4) and to nortropinyl benzoate 18 (affording 20). Adding an additional methyl group to the tropine nitrogen atom of Nphenetyl derivatives (to obtain compounds 10 and 22, respectively) results again in identical GE values (0.55 kcal·mol -1 per heavy atom, (Figure 4) . Remarkably, for Ac-AChBP, we observed significant differences in the trends for the dibenzosuberyl-substituted tropines and benzoate-substituted tropines (Figure 4) . Addition of a phenetyl group to ether 9 does not result in an increase in Ac-AChBP binding affinity (GE = 0 kcal·mol -1 per heavy atom) whereas the same modification for benzoate ester 18 yields a substantial GE of 0.38 kcal·mol -1 per heavy atom. Even more pronounced differences are observed for the subsequent methylation of the tropine nitrogen atom of ether 4 and ester 20. In the case of ether 1, this minor modification affords a significant increase in Ac-AChBP binding affinity (GE = 1.65 kcal·mol -1 per heavy atom), whereas quaternization of ester 20 results in a large drop in binding affinity (GE = -0.96 kcal·mol -1 per heavy atom). These SAR differences between dibenzosuberyl tropinyl ethers 9, 4 and 10 and the benzoate tropine esters 18, 20 and 22 are indicative of different binding modes between the two compound series. Since we have provided structural evidence that benzoate ester 20 ((R)-enantiomer) is interacting with the lobeline pocket in Ac-AChBP (2Y57.pdb), 14 a likely explanation for the observed SAR differences between the compound series is that dibenzosuberyl ether 4 is not interacting with the lobeline pocket. In the same study, we have shown that the loss of Ac-AChBP affinity upon quaternization of the α-hydroxyl-substituted analog of 24 (23, (R)-enantiomer) is due to loss of interactions with the lobeline pocket. As such, the beneficial effect of quaternization of the dibenzosuberyl ether 4, is another indication that 4 is not interacting with the lobeline pocket in Ac-AChBP. In addition, we have provided Chapter 5 Structure-based design, synthesis, and structure-activity relationships of dibenzosuberyl-and benzoate substituted tropines as ligands for acetylcholine-binding protein 109 strong evidence that due to the lack of stabilization of the tyrosine-flip of Tyr91, the lobeline pocket in Ls-AChBP is less accessible compared to Ac-AChBP. 14 The current results indicate that in Ls-AChBP, the N-phenetyl substituents of ligands 4-6 are likely to be accommodated by a (hydrophobic) part of the binding site different than the lobeline pocket.
Figure 5. Overlay of lobeline (PDB: 2BYS, black ball and sticks) and compound 21 ((R)-enantiomer, PDB: 2Y56, light grey ball and sticks) bound to Ac-AChBP showing that similar to lobeline the -hydroxyphenetyl group of 21 is interacting with the lobeline pocket. However, in contrast to lobeline the -hydroxyl group is not engaged in the formation of hydrogen bonds with the carbonyl backbones of Ser144 or Trp145 but is pointing in an opposite direction and involved in van der Waals interactions with Tyr193.
Our docking efforts suggested that incorporation of hydroxyl substituents at the α-or meta positions of the N-phenetyl substituents of the dibenzosuberyl as well as the benzoate series could increase binding affinity by the formation of additional hydrogen bonds with the lobeline pocket. However, for both series of compounds, introduction of hydroxyl moieties at the α-and meta-positions of the N-phenetyl Chapter 5 Structure-based design, synthesis, and structure-activity relationships of dibenzosuberyl-and benzoate substituted tropines as ligands for acetylcholine-binding protein moiety diminishes binding affinity for Ls-AChBP as well as Ac-AChBP. For LsAChBP and the dibenzosuberyl-substituted tropines, this can be explained by a different binding mode than predicted, i.e., no interaction of the N-phenetyl moiety with the lobeline pocket. It is noted that the N-phenetyl substituted tropine benzoates 20 and 24 have been shown by X-ray co-crystal structures to interact with the lobeline pocket in Ac-AChBP. Nevertheless, the co-crystal complex of AChBP with 24, shows that the α-hydroxyl group of 24 ((R)-enantiomer) is not engaged in a hydrogen bond with the backbone carbonyl oxygen atoms of Ser144 or Trp145 but instead, is involved in van der Waals interactions with Tyr193, providing an explanation for the observed detrimental effect on binding affinity of the -hydroxyl group ( Figure 5 ). Due to desolvation penalties, the positioning of hydrogen-bonding groups needs to be near optimal in order to be beneficial in terms of binding affinity. 28, 29 Apparently, upon introduction of one or two metahydroxyl groups to benzoate ester 12, the desolvation penalty dominates, indicating that the positioning of the α-hydroxyphenetyl moiety in the lobeline pocket does not allow for strong hydrogen bond formation with the carbonyl backbone of Thr89 and/or the side chain of Asp195. Interestingly, ionic and hydrogen bond interactions with Asp195 have been observed for α-conotoxins in complex with Ac-AChBP with Tyr91 in a g-conformation (closed lobeline pocket, PDB: 2UZ6 and 2BYP), showing that it is possible for ligands to interact with this residue. 12, 30 These ligands were also tested on the 7 and 42 nicotinic receptors. None of these compounds showed any affinity for the 42 receptor. However, the binding affinities of the dibenzosuberyl-substituted tropines for the 7 receptor were similar to the affinities determined for Ac-AChBP. As seen with the AChBPs, quaternization of the tropine nitrogen atom increases the binding affinity. None of the novel derivatives had higher affinity for the 7 nAChR than the initial in silico hit 1. No large changes in affinity between the benzoate esters 16, 18, 20-26, 29 and 30 for the α7 nAChR were observed. All binding affinities for the N-phenetyl substituted benzoate esters are within 0.9 log units (pK i = 4.6 -5.5). Interestingly, the compound in this series with the highest affinity for the 7 nAChR is fragment 5 (pKi = 5.5). Apparently, all the introduced substituents on the tropine nitrogen atom even as small as methyl decrease affinity for this nAChR subtype, indicating that the lobeline pocket in the α7 nAChR subtype is not being addressed.
It is noted that the optimization of the initial in silico hits that has been achieved for both AChBPs does not translate to increased affinities for the α7 and α4β2 receptors. Even though it has been shown that AChBP can be used to identify new ligands for nicotinic receptors, the current study indicates its limitations in directly using AChBP X-ray structures for structure-based optimization of nicotinic receptor ligands. Nevertheless, the current and our previous studies have provided strong evidence that interactions with the lobeline pocket can render ligands selective for Ac-AChBP. These findings may be of interest in the design of subtype-selective ligands for human nicotinic receptors. The gatekeeper tyrosine residue is conserved among the human nAChR subtypes, whereas the residue (Ser165 in Ac-AChBP) that stabilizes the open lobeline pocket conformation is located in a 
Conclusion
In summary, novel dibenzosuberyl-and benzoate substituted tropines were designed using a structure-based fragment-merging hit-optimization approach. Distinct SAR of the novel compound series was observed between two AChBP species variants and between the α7 and α4β2 nAChR subtype. The AChBP species differences were indicative of a difference in accessibility of a ligandinducible subpocket between AChBPs from different organisms. Hereby, we have identified a region within the pocket that can be scrutinized to unravel its importance for obtaining selectivity amongst the fast number of nicotinic receptor subtypes. In addition, our studies underline that structure-based fragment merging can be an efficient method for increasing binding affinity. The novel compounds described in this study and the obtained structural understanding can be used to focus on the subtle differences between the AChBPs and nicotinic receptors, possibly the lobeline pocket accessibility, and binding pose differences, that cause the observed selectivity profiles and SAR differences. 
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Materials and Methods
Molecular docking
Ligand preparation Three-dimensional structures of the ligands were generated using MOE (v2008.10, Chemical Computing Group, Montreal, Canada). Subsequently, the ligands were protonated according to physiological pH and stereoisomers were generated when necessary. Partial atomic charges were calculated and the molecules were energy minimized in vacuo using the MMFF94x force field in MOE. Ligands were stored as mol2 files.
Template preparation
Co-crystal structures of Ac-AChBP in complex with lobeline (2BYS, chains A and E) and compound 31 (2W8F, chains A and B) were used for our docking studies. The ligands and all water molecules except for water molecules number 92 and 96 (2BYS, chain V) were removed. These water molecules are involved in a hydrogen bond network that interacts with the carbonyl oxygen atom of lobeline and were expected to be able to interact with the carbonyl oxygen atoms of the benzoate
Chapter 5
Structure-based design, synthesis, and structure-activity relationships of dibenzosuberyl-and benzoate substituted tropines as ligands for acetylcholine-binding protein substituted series in a similar fashion. Hydrogen atoms were added, partial atomic charges were calculated and a steepest-descent energy minimization was performed using the AMBER99 force field in MOE. In the 2W8F structure, we manually changed the rotamer of Y91 (numbering in 2W8F; corresponds to Y93 in 2BYS) in such a way that it was similar to Y93 of the lobeline-bound structure (2BYS), i.e., from the g-to t conformation. To this end, Y93 was assigned another rotamer that allowed for a hydrogen bond between Y93 and S167 of the complementary side.
Docking procedure
Docking studies were performed using the GOLD docking program (version 4.0, CCDC, Cambridge, UK) 25 and the ChemScore scoring function and default settings. The binding pocket was defined within a radius of 16 Å from W147 (atom NE1).
Expression and purification of AChBPs
Hexahis-Lymnaea stagnalis-acetylcholine binding protein (Ls-AChBP) and hexahisAplysia californica-acetylcholine binding protein (Ac-AChBP) were expressed using the Bac-to-Bac Baculovirus Expression System (Invitrogen, Carlsbad, CA, USA) following the manufacturer"s recommendations. Secreted protein was trapped on an HIS-Select Cartridge (Sigma, St. Louis, MO, USA). The cartridge was washed with 24 ml 10 mM imidazole, left overnight at 4ºC in 250 mM imidazole and thereafter eluted with 5 ml of 250 mM imidazole. A Slide-A-Lyzer Dialysis Cassette (Pierce, Rockford, IL, USA) was used according to manufactures recommendations to strongly decrease the concentration of imidazole. The purity of the protein was checked on a SDS gel and the protein concentration was determined by a Bradford analysis. Protein aliquots were stored at -80˚C until use.
Expression and purification of nicotinic receptors
Human neuroblastoma cells (SH-SY5Y) expressing human 7 receptor were obtained from Christian Fuhrer (Department of Neurochemistry, Brain Research Institute, University of Zurich). 26 Human 42 receptors were obtained using a transient transfection of HEK293t cells. To this end, HEK293t cells were maintained in Dulbecco"s Modified Eagle Medium (DMEM) supplemented with 10% Fetal Calf Serum (FCS), 50 IU/mL penicillin, and 50 g/mL streptomycin in 5% CO 2 humidified atmosphere at 37 °C. Approximately 2 million cells were seeded in a 10 cm dish and cultured overnight before transfection. For transfection of each dish of cells, the transfection mixture was prepared in 0.6 mL PBS and contained 0.3 g of human 4 subunit plasmid, 2.7 g of human 2 subunit plasmid, 3.0 g of ric3 and 24 L of 1 mg/mL 25 kDa linear polyethyleneimine (Polyscience, Inc., USA). The mixture was incubated for 10-15 minutes at room temperature before it was added into the monolayer cell culture loaded with 6 mL of fresh and pre-warmed cell culture medium. Two days after transfection, the cells were washed with PBS, collected as pellet by centrifuging, and stored at -80 °C until use. 
Radioligand binding assay on nicotinic receptors
Binding assays for human 42 and 7 receptors were performed in a similar way as described for Ls-AChBP, but with a classical filtration assay. The cells were homogenized immediately before use. In the 42 assay, [ H]MLA (American Radiolabeled Chemicals, Inc, specific activity ~100 Ci/mmol) was used at a final concentration of 2 nM for the 7 assay. Bound radioligand was collected on 0.3% polyethyleneiminepretreated Unifilter-96 GF/C filters (Perkin Elmer) using ice-cold 50 mM Tris buffer at pH 7.4. After drying the filters, scintillation fluid (MicroScint, Perkin Elmer) was added and the radioactivity was measured in a Wallac 1450 MicroBeta liquid scintillation counter. Radioligand saturation experiments were performed with nicotine to determine non-specific binding. The concentration of nicotine was 100 M for the 42 receptor and 1 mM for the 7 receptor.
Data analysis
All radioligand binding data were evaluated by a non-linear, least squares curve fitting procedure using Graphpad Prism  (version 4.01, GraphPad Software, Inc., San Diego, CA). All data are represented as mean ± SEM from at least three independent experiments.
Chemistry
General
Chemicals and reagents were obtained from commercial suppliers and were used without further purification, unless mentioned otherwise. DCM, THF and toluene were distilled under an atmosphere of nitrogen from CaH 2 prior to use. Yields given are isolated yields. Flash column chromatography was typically carried out on a Flashmaster or Biotage flash chromatography system, using prepacked columns with the UV detector operating at 254 nm. All melting points are uncorrected and were measured on an Optimelt automated melting point system from Stanford research systems. All 1 H NMR and 13 C NMR spectra were measured on a Bruker 250 or Bruker 400 at T = 300 K or on a Bruker 500 at T = 296 K unless mentioned otherwise. Analytical HPLC-MS analyses were conducted using two different 
3α-((10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)oxy)-8-methyl-8-azabicyclo[3.2.1]octane maleate (8)
. 5-Chlorodibenzosuberane (11.9 g, 96%, 50.0 mmol) was added to a round bottom flask containing tropine (14.4 g, 98%, 100 mmol) dissolved in freshly distilled toluene (50 mL). The mixture was stirred overnight at room temperature. The next day, a very thick white suspension had formed. Toluene (50 mL) was added and the mixture was heated at reflux for 1 hours. When cooled down to room temperature, the mixture was filtered over glass under suction. Evaporation of the filtrate afforded 18.2 g of a slight yellow colored oil. A solution of maleic acid (5.64 g, 48.6 mmol) and crude product in EtOAc (750 mL) was concentrated in vacuo to ~400 mL and set aside. Overnight, white needleshaped crystals formed that were isolated by filtration over glass. C. The resulting mixture was stirred for 5 hours at room temperature. Formed MnO 2 was removed by filtration over paper under suction. The slightly yellow colored filtrate was concentrated in vacuo to ~50 mL.
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Water (50 mL) was added and the mixture was extracted with DCM (3 x 100 mL), followed by extraction with EtOAc (2 x 100 mL). The combined organics were dried with Na 2 SO 4 (s) and concentrated in vacuo to afford 5.82 g of a yellow colored oil.
Crude product was dissolved in EtOAc (~150 mL) and a solution of maleic acid (1.78 g, 15.3 mmol) in EtOAc (~125 mL) was added. After a few seconds, a white precipitate starts to form. Further precipitation was established by storing the mixture in the freezer overnight. The crude product was isolated by filtration over glass under suction, washed with EtOAC and dried in a vacuum stove to afford 4.14 g (46%) of a white solid. The obtained maleate salt was used without further purification in the experiments described below. However, for biological characterization purposes, a small amount of the maleate salt was recrystallized from acetone to obtain pure material. 
3α-((10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)oxy)-8α-phenetyl-8-azabicyclo[3.2.1]octane maleate (4)
. NaBH(OAc) 3 (318 mg, 1.50 mmol) was added to a round bottom flask containing the free base of 3α-((10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)oxy)-8-azabicyclo[3.2.1]octane (9) (431 mg, 1.35 mmol) and phenylacetaldehyde (170 μL, 90%, 1.35 mmol) dissolved in DCE (5 mL). The mixture was stirred overnight at room temperature under an atmosphere of nitrogen. Saturated NaHCO 3 (10 mL) was added, phases were separated and aqueous phase was extracted with DCM (2 x 10 mL). The combined organics were dried with Na 2 SO 4 (s) and concentration in vacuo afforded 513 mg (90%) of a slight yellow colored oil. For biological characterization purposes, 200 mg of the crude product was converted into its maleate salt by addition of a saturated ethereal solution of maleic acid to an ethereal solution of the crude product. 3α-((10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)oxy)-8-azabicyclo-[3.2.1]octan-8-yl)-1-hydroxyethyl) (13) . Aluminium isopropoxide (61.03 g, 300 mmol) was placed in three neck round bottom flask. To this 2-propanol (200 mL) was added and the mixture was brought to reflux with stirring. Tropinone (13.95 g, 100 mmol) was dissolved in 2-propanol (100 mL) and added dropwise to the refluxing solution over a period of 45 minutes. Refluxing continued 24 hours and the reaction was allowed to continue boiling 45 minutes without a condenser to remove acetone produced during the reaction. Water (18 mL) was added dropwise to the boiling solution, resulting in foam formation and formation of a white precipitate. The mixture was filtered and the residue was washed with hot 2-propanol and EtOH. The filtrate was filtered once more and then evaporated under reduced pressure to give a red oil which crystallised over time. This residue was recrystallized from hexane (170 mL) and EtOAc (7 mL) affording 8.82 g (62%) of white needle-shaped crystals. 
3-(2-(
3β-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane (17).
Benzoyl chloride (7.7 mL, 66 mmol) was added in a dropwise manner to a boiling solution of β-tropine (13) (8.46 g, 60 mmol) and TEA (9.2 mL, 66 mmol) in freshly distilled toluene (175 mL). The mixture was heated at reflux temperature for 4 hours and stirred at room temperature overnight. The reaction mixture was washed with a saturated NaHCO 3 solution (3x 60 mL) and subsequently dried with Na 2 SO 4 (s) . Upon drying, a white precipitate starts to form and the mixture was directly filtered over paper under suction. The residue was extensively washed with DCM. The filtrate was concentrated in vacuo to afford a white solid. This was partially dissolved in refluxing 1:1 hexane and ethyl acetate (400 mL) and filtered while hot to give 2.27 g (15%) of free base 8. The filtrate was evaporated to a solid under reduced pressure. This was dissolved in Et 2 O (40 mL) and a 2M solution of HCl in Et 2 O (40 mL) was added. A white precipitate formed that was isolated by filtration over paper affording 10.51 g (62%) of a white solid. Mp: 274.1-275.3 °C. 3β-benzoyloxy-8-azabicyclo[3.2.1]octane hydrochloride (19) . 3β-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane (17) (9.02 g, 35.5 mmol) was suspended in 50 mL DCE. Upon cooling in an ice/water bath and under an atmosphere of nitrogen, 1-chloroethyl chloroformate (7.8 mL, 72 mmol) was added in a dropwise manner. The mixture was heated to reflux temperature and stirred for 19 hours. The mixture was concentrated in vacuo and dissolved in MeOH (50 mL) and left refluxing for 4 and stirring at room temperature for 18 hours. The mixture was then concentrated in vacuo leaving yellow crystals. These were recrystallized from 2-propanol. The resulting crystals were then dissolved in DCM (150 mL), mixed with a solution of 10% NaHCO 3 in water (150 mL) and separated. The aqueous phase was extracted with DCM (2 x 75 mL). The combined organic phases were dried with Na 2 SO 4 (s), filtered and concentrated in vacuo to give crude free base in a yield of 76%. A portion of the crude product (1.00 g, 4.32 mmol) was purified over SiO 2 using flash chromatography (gradient from 1% MeOH to 10% MeOH in EtOAc containing 1% TEA) resulting in an isolated yield of 65%. Mp: 63.1-64.8 °C. (18) (2.67 g, 10 mmol) and TBTU (3.21 g, 10 mmol) were dissolved in DMF (100 mL) containing TEA (2.8 mL, 20 mmol). The mixture was stirred for 3 hours at room temperature. Water (100 mL) was added and the resulting suspension was extracted with Et 2 O (3 x 75 mL). The combined organics were washed with brine (75 mL) and dried with MgSO 4 (s). Concentration in vacuo afforded 3.20 g (88%) of a white solid that was dissolved in freshly distilled THF (90 mL). Upon cooling in an ice/water bath and under an atmosphere of nitrogen, 1M BH 3 . THF in THF (27 mL, 27 mmol) was added in a dropwise manner. The mixture was heated to room temperature and stirred overnight. MeOH (20 mL) was added with caution. The mixture was concentrated in vacuo and dissolved in MeOH (~10 mL) and re-concentrated in vacuo. This procedure was repeated two more times in order to remove borane as its methyl ester. was dissolved in freshly distilled toluene (1 mL). Iodomethane (30 μL, 0.5 mmol) was added and the mixture was set aside at room temperature over the weekend. A white precipitate (~30 mg, 20%) formed and was isolated by decantation. A supplement of iodomethane (100 μL, 1.6 mmol) was added to the remaining supernatant and the mixture was set aside for 2 weeks. Again a white precipitate (~90 mg) had formed that was isolated by decantation and combined with the first crop. The crude product was washed with toluene and recrystallized from 2-propanol/methanol affording 70 mg (47% (18) (2.67 g, 10 mmol) and TBTU (3.21 g, 10 mmol) were dissolved in DMF (100 mL) containing TEA (2.8 mL, 20 mmol). The mixture was stirred for 3 hours at room temperature. Water (100 mL) was added and the resulting suspension was extracted with Et 2 O (3 x 75 mL). The aqueous phase was acidified to pH 5-6 and extracted once more with Et 2 O (3 x 75 mL). The combined organics were washed with brine (75 mL) and dried with MgSO 4 (s). Concentration in vacuo afforded 2.35 g (64%) of a white solid that was dissolved in freshly distilled THF (15 mL). Upon cooling in an ice/water bath and under an atmosphere of nitrogen, 1M BH 3 . THF in THF (4.2 mL, 4.2 mmol) was added in a dropwise manner. The mixture was heated to room temperature and stirred overnight. MeOH (20 mL) was added with caution. The mixture was concentrated in vacuo and dissolved in MeOH (~5 mL) and re-concentrated in vacuo. This procedure was repeated two more times in order to remove borane as its methyl ester. 576 mg of a white solid was obtained. The crude product was purified using reversed phase preparative chromatography (C18 derivatized (17%), endcapped silicycle column with gradient elution from 10 to 90% acetonitrile in 0.04% NH 4 THF in THF (1.0 mL, 1.0 mmol) was added in a dropwise manner. The mixture was stirred for 1.5 hours under cooling in the ice/water bath. MeOH (5 mL) was added with caution. The mixture was concentrated in vacuo and dissolved in MeOH (~10 mL) and re-concentrated in vacuo. This procedure was repeated two more times in order to remove borane as its methyl ester. A slight orange colored solid was obtained that was purified over SiO 2 using flash chromatography (gradient from 5% MeOH to 20% MeOH in DCM) to yield 146 mg (76%) of an off-white solid. THF in THF (1.0 mL, 1.0 mmol) was added in a dropwise manner. The mixture was stirred for 45 minutes under cooling in the ice/water bath. MeOH (1 mL) was added with caution. The mixture was concentrated in vacuo and dissolved in MeOH (~5 mL) and re-concentrated in vacuo. This procedure was repeated two more times in order to remove borane as its methyl ester. 157 mg of colourless oil was obtained that was purified over SiO 2 using flash chromatography (gradient from 2% MeOH to 20% MeOH in DCM) to yield 55 mg (39%) of a colourless oil. For biological characterization purposes (easier handling), the oily freebase was converted into its maleate salt by dissolving the freebase in Configuration of quaternary ammonium salts 10, 22 and 23. Methylation using iodomethane afforded the quaternary ammonium salt 10 with the phenetyl moiety in an endo-configuration as determined by 2D NMR spectroscopy at 393 K. The 1 H NMR multiplet from 2.39-2.19 ppm can be ascribed to the tropine ethylene bridge due to the absence of COSY and NOESY coupling to H(3). In contrast, COSY coupling of H(3) with hydrogens of C(2) and C(4) is observed. The identification of the ethylene bridge allows determination of the configuration of the quaternary nitrogen. NOESY coupling of the methyl substituent hydrogens with the tropine ethylene bridge (C(6) and C(7)) and NOESY coupling of CH 2 (9) with hydrogens of C(2) and C (4) shows that the phenetyl substituent has an endo-and that the methyl substituent must have an exo-configuration. Treatment of endo-epimer 20 with iodomethane resulted in formation of the endo-phenetyl substituted quaternary ammonium derivative 22 (Supplementary Scheme 4) . The epimeric configuration was confirmed by performing 2D NMR. The singlet at 2.56 ppm can be ascribed to the tropine ethylene bridge due to the absence of NOESY coupling to H(3). Similar to compound 2, NOESY shows coupling of H(3) with the axial and equatorial hydrogens of C(2) and C(4). The identification of the ethylene bridge 1 H NMR signals allows determination of the configuration of the quaternary nitrogen. NOESY coupling of the methyl substituent with the tropine ethylene bridge hydrogens and NOESY coupling of CH 2 (9) with the axial hydrogens of C(2) and C (4) shows that the phenetyl substituent must have an endo-while the methyl substituent is in an exo-configuration. Reaction of alpha-hydroxyl substituted phenetylamine 21 with iodomethane afforded similar as before the endo-phenetyl substituted quaternary ammonium derivative 23 as confirmed by 2D NMR. As with 10 and 22, the 1 H NMR signal of the tropine ethylene bridge can be identified due to the absence of NOESY coupling of to H(3). This signal (multiplet at 2.61-2.48 ppm) shows clear NOESY coupling with the methyl substituent indicative of an exoconfiguration. The lack of NOESY coupling of CH 2 (9) with the ethylene bridge hydrogens is indicative of an endo-configuration of the α-hydroxyphenetylmoiety. See Supplementary Scheme 1. 
